Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding: Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent

Author:   Robert S. Danziger ,  John T. Scott
Publisher:   now publishers Inc
ISBN:  

9781680838206


Pages:   112
Publication Date:   08 September 2021
Format:   Paperback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $211.20 Quantity:  
Add to Cart

Share |

Government Royalties on Sales of Pharmaceutical and Other Biomedical Products Developed with Substantial Public Funding: Illustrated with the Technology Transfer of the Drug-Eluting Coronary Stent


Add your own review!

Overview

This study develops a detailed description of the successful technology transfer of an invention — the drug-eluting coronary stent — originating in intramural research within the US National Institutes of Health. The history of the commercialization of the invention is used to illustrate a new policy, proposed and explained in this study, for the payment to the government of royalties on the sales of biomedical products developed with substantial public funding provided through indirect as well as direct funding avenues. The proposed policy addresses concerns about the high prices that taxpayers as consumers pay for biomedical products that were developed with funding from the taxpayers as investors. The study explains the theoretical circumstances in which the policy would not adversely affect the appropriate level of R&D investment, and then uses the history of the drug-eluting coronary stent as an example where biomedical R&D is consistent with those circumstances.

Full Product Details

Author:   Robert S. Danziger ,  John T. Scott
Publisher:   now publishers Inc
Imprint:   now publishers Inc
Weight:   0.170kg
ISBN:  

9781680838206


ISBN 10:   1680838202
Pages:   112
Publication Date:   08 September 2021
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

1. Introduction 2. The Two Avenues for Public Funding of Pharmaceutical and Other Biomedical R&D 3. The Story of Drug-Eluting Coronary Stents 4. The Incentives Issue 5. The Circumstances Affecting Incentives for the Development of Drug-Eluting Stents 6. A Proposal for Government Royalties for Biomedical Products Developed with Substantial Public Funding for R&D 7. Conclusion Acknowledgements Appendices A. Incomplete Pass Through of the Royalty to Price Given Market Power About the Authors References

Reviews

Author Information

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

wl

Shopping Cart
Your cart is empty
Shopping cart
Mailing List